TRL 382
Alternative Names: TR-L-382Latest Information Update: 24 Mar 2016
Price :
$50 *
At a glance
- Originator Toray
- Class
- Mechanism of Action Cyclo-oxygenase 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 24 Mar 2016 Discontinued - Preclinical for Neuropathic pain in Japan (PO)
- 21 Oct 2009 Preclinical trials in Neuropathic pain in Japan (PO)